Leave a little sharper than you arrived.

News, calculators, learning and daily puzzles — pick any one and leave a little further along.

Today’s puzzle

Today's News

See all briefs
OncLive · 2 min

EU greenlights teclistamab monotherapy for multiple myeloma as early as first relapse

The European Commission has expanded the approval of teclistamab (Tecvayli) monotherapy to cover adults with relapsed/refractory multiple myeloma after just one prior therapy. The decision is backed by phase 3 MajesTEC-9 trial data showing a 71% reduction in disease progression or death vs standard chemotherapy regimens. Nearly two-thirds of patients on teclistamab achieved a complete response or better.

Healio · 2 min

Once-weekly insulin Awiqli gets FDA green light for kids with type 2 diabetes

Healio · 2 min

FDA greenlights at-home Skyrizi induction for Crohn's disease

Gastroenterology Advisor · 3 min

FDA approves first immunotherapy for locally advanced rectal cancer, potentially sparing patients from surgery and chemo

Everything on Curie.MD

NeurologyPlay & LearnLearn what’s new in your field, a few minutes at a time.Start learningCardiologyCalculatorsEnter the case once. See every relevant score, side by side.Open a calculatorAll fieldsDaily GamesThree new clinical puzzles every morning.Play today

Get Curie’s Weekly Dose

What changed in clinical practice, policy, and coverage, and what it means for your patients.

Subscribe free Free. Weekly. Unsubscribe anytime.